You administer your CJC-1295 / Ipamorelin, which sends a powerful signal to the pituitary saying, "Release GH!" But if you've just eaten, your body is also sending a signal via insulin and Somatostatin saying, "Don't release GH!" It's a biological tug-of-war, and unfortunately for your protocol, Somatostatin almost always wins
FINNALI: a prospective cohort study
R., Chocano-Bedoya, P
Where the component evidence is strongest and weakest GHK-Cu is the best-characterized of the four, with a substantial mechanistic and topical-skincare literature behind it which makes it a reasonable anchor to build a blend around
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that binds selectively to GHRH receptors on your pituitary somatotroph cells
This modification is thought to lead to a prolonged presence in plasma, with immunoreactive species detectable well beyond 24 hours post-exposure in experimental observations